CHICAGO — Chicago Biotech Startup Unveils AI to Speed Up Breakthrough Drugs- In the wake of Evozyne's hiring of a seasoned tech-company executive as CEO, the Chicago-based biotech company announced it has developed an AI model that it hopes will revolutionize development of new therapeutic proteins, significantly accelerating the time it takes to bring drugs treating rare diseases to market....By: Cozen O'Connor.